CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE
| Brand name | TRALEMENT |
|---|---|
| Active ingredient | CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE |
| Strength | EQ 0.3MG COPPER/ML;EQ 55MCG BASE/ML;EQ 60MCG SELENIUM/ML;EQ 3MG BASE/ML (1ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | July 2020 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12150957 | July 2041 | use U-3899 |
| 12150956 | July 2041 | use U-3899 |
| 11975022 | July 2041 | use U-3899 |
| 11998565 | July 2041 | product |
| 11786548 | July 2041 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.